Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial - Murray, JA; Wassaf, D; Dunn, K (Lancet Gastroenterol Hepatol, 2023)